Qube Research & Technologies (QRT)
FBLG icon

Qube Research & Technologies (QRT)’s FibroBiologics FBLG Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23K Buy
+24,313
New +$28.2K ﹤0.01% 3212
2026
Q1 		– Sell
-842
Closed -$3.79K – 4234
2025
Q4 		$3.79K Sell
842
-656
-44% -$4.62K ﹤0.01% 3547
2025
Q3 		$16.4K Sell
1,498
-207
-12% -$2.48K ﹤0.01% 3305
2025
Q2 		$21.2K Buy
+1,705
New +$30.8K ﹤0.01% 3252

Other funds holding FBLG

CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FBLG Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in FibroBiologics (FBLG) in Q2 2026: 24,313 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #3212 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in FBLG as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in FBLG in Q2 2025 and has held it in 4 quarters since. 16 funds tracked by Wall St. Rank hold FBLG as of Q2 2026.

  • Qube Research & Technologies (QRT) held 24,313 shares of FibroBiologics worth $23K as of Q2 2026.
  • FibroBiologics was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • FibroBiologics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3212 holding.
  • Qube Research & Technologies (QRT) first reported a position in FibroBiologics in Q2 2025 and has held it in 4 quarters since.
  • 16 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.